West Pharmaceutical Servi...

NYSE: WST · Real-Time Price · USD
246.62
0.42 (0.17%)
At close: Aug 15, 2025, 3:03 PM

West Pharmaceutical Services Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.96B 2.9B 2.89B 2.88B 2.88B 2.93B 2.95B 2.93B 2.87B 2.88B 2.89B 2.91B 2.93B 2.88B 2.83B 2.68B 2.52B 2.33B
Cost of Revenue
1.92B 1.89B 1.89B 1.87B 1.85B 1.84B 1.82B 1.81B 1.77B 1.76B 1.75B 1.73B 1.73B 1.69B 1.66B 1.59B 1.53B 1.45B
Gross Profit
1.04B 1B 998.5M 1B 1.03B 1.09B 1.13B 1.11B 1.09B 1.12B 1.14B 1.17B 1.19B 1.19B 1.18B 1.09B 992.7M 872.7M
Operating Income
586.1M 554.1M 569.9M 571.2M 587.2M 643.5M 676M 644.8M 653.7M 699.6M 734M 788.3M 783.5M 766.4M 752.3M 684.4M 602.2M 494.5M
Interest Income
17.1M 17.5M 19.6M 24.2M 28.4M 29.4M 28M 21.5M 14.2M 9.6M 5.1M 2.5M 1.4M 1.2M 1M 900K 700K 700K
Pretax Income
611.2M 582.4M 600.2M 604.8M 627.1M 683.8M 715.7M 676.1M 626.4M 669.2M 700.6M 750.6M 790.7M 769M 748.9M 682.1M 598.7M 489.7M
Net Income
487.7M 467.2M 492.7M 499.6M 524.9M 568.7M 593.4M 559.4M 518.7M 552.1M 585.9M 630.6M 685.6M 684.4M 661.8M 612.5M 519.2M 423.1M
Selling & General & Admin
352.7M 339.8M 338.5M 343.2M 348.7M 354.1M 353.4M 349.1M 326.4M 319.5M 316.9M 329.2M 354.8M 366M 362.8M 341.1M 325.4M 310.4M
Research & Development
69.4M 67.8M 69.1M 69M 69.9M 68.9M 68.4M 65.9M 63.1M 61M 58.5M 56.3M 55.8M 55.2M 52.8M 52M 51.4M 48.4M
Other Expenses
35.2M 38.5M 21M 19.7M 20.9M 21.6M 31.4M 53.3M 49.6M 42.8M 26.8M 900K 800K 900K 7.9M 8.8M 13.7M 19.4M
Operating Expenses
457.3M 446.1M 428.6M 431.9M 439.5M 444.6M 453.2M 468.3M 439.1M 423.3M 402.2M 386.4M 411.4M 422.1M 423.5M 401.9M 390.5M 378.2M
Interest Expense
400K 1.8M 3M 5M 7.2M 8.4M 9M 9.5M 8.8M 7.9M 7.9M 8.8M 8.4M 8.5M 8.2M 7.7M 8M 8.1M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.37B 2.34B 2.32B 2.31B 2.29B 2.29B 2.27B 2.28B 2.21B 2.18B 2.15B 2.12B 2.15B 2.11B 2.08B 2B 1.92B 1.83B
Income Tax Expense
123.5M 115.2M 107.5M 105.2M 102.2M 115.1M 122.3M 116.7M 107.7M 117.1M 114.7M 120M 111.6M 99.7M 107.2M 93.4M 102.5M 86.2M
Shares Outstanding (Basic)
72.3M 72.5M 73M 72.8M 73M 73.5M 74.1M 74.3M 74.3M 74.5M 74.4M 74.4M 74.4M 74.4M 74.5M 74.1M 74M 73.9M
Shares Outstanding (Diluted)
72.8M 73M 73.7M 73.4M 73.7M 74.3M 75M 75.3M 75.4M 75.7M 75.6M 75.7M 75.8M 76M 76.4M 76M 75.7M 75.8M
EPS (Basic)
6.72 6.42 6.75 6.81 7.11 7.68 7.99 7.52 6.97 7.41 7.87 8.47 9.22 9.22 8.92 8.27 7.01 5.72
EPS (Diluted)
6.68 6.37 6.69 6.74 7.03 7.58 7.88 7.41 6.86 7.29 7.73 8.30 9.02 9.00 8.70 8.06 6.84 5.58
EBITDA
759.6M 729.5M 743.2M 743.7M 763.9M 816.7M 843.8M 800M 741.8M 776.9M 804.2M 861.6M 907.1M 892.5M 879.4M 806.6M 721.9M 610.4M
EBIT
597.3M 570.4M 588.5M 593.8M 618.5M 675.9M 707M 668M 616.5M 655.1M 685M 739.1M 783.6M 770.3M 757.1M 689.8M 606.7M 497.8M
Depreciation & Amortization
162.3M 159.8M 155.4M 150.6M 146.1M 141.3M 137.3M 132.5M 126.6M 122.6M 120.6M 123.9M 124.1M 122.8M 122.3M 116.4M 114.8M 112.2M